Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty: The effectiveness of a single pre-operative dose

OBJECTIVES: We have increased the dose of tranexamic acid (TXA) in our enhanced total joint recovery protocol at our institution from 15 mg/kg to 30 mg/kg (maximum 2.5 g) as a single, intravenous (IV) dose. We report the clinical effect of this dosage change. METHODS: We retrospectively compared two...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrison, R. J. M., Tsang, B., Fishley, W., Harper, I., Joseph, J. C., Reed, M. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579309/
https://www.ncbi.nlm.nih.gov/pubmed/28851694
http://dx.doi.org/10.1302/2046-3758.68.BJR-2017-0005.R1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579309/
https://www.ncbi.nlm.nih.gov/pubmed/28851694
http://dx.doi.org/10.1302/2046-3758.68.BJR-2017-0005.R1

Ejemplares similares